Mucinous cystadenocarcinoma natural history: Difference between revisions
(Mahshid) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mucinous cystadenocarcinoma}} | {{Mucinous cystadenocarcinoma}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Qurrat}}, {{Ammu}} | ||
==Overview== | ==Overview== | ||
If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself. Common complications of mucinous cystadenocarcinoma include [[metastasis]] and [[inguinal hernia]]. The presence of [[metastasis]] is associated with a particularly poor prognosis among patients with mucinous cystadenocarcinoma. | If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself. Common complications of mucinous cystadenocarcinoma include [[metastasis]] and [[inguinal hernia]]. The presence of [[metastasis]] is associated with a particularly poor prognosis among patients with mucinous cystadenocarcinoma. | ||
==Natural History== | ==Natural History== | ||
* If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself. Some of them may develop metastasis to gastrointestinal tract.<ref name="Guruprasad2012">{{cite journal|last1=Guruprasad|first1=Bhat|title=Mucinous cystadenocarcinoma of ovary: Changing treatment paradigms|journal=World Journal of Obstetrics and Gynecology|volume=1|issue=4|year=2012|pages=42|issn=2218-6220|doi=10.5317/wjog.v1.i4.42}}</ref> | * If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself. Some of them may develop metastasis to the gastrointestinal tract.<ref name="Guruprasad2012">{{cite journal|last1=Guruprasad|first1=Bhat|title=Mucinous cystadenocarcinoma of ovary: Changing treatment paradigms|journal=World Journal of Obstetrics and Gynecology|volume=1|issue=4|year=2012|pages=42|issn=2218-6220|doi=10.5317/wjog.v1.i4.42}}</ref> | ||
==Complications== | ==Complications== | ||
* Common complications are: | * Common complications are: | ||
Revision as of 18:19, 19 April 2019
|
Mucinous cystadenocarcinoma Microchapters |
|
Differentiating Mucinous Cystadenocarcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mucinous cystadenocarcinoma natural history On the Web |
|
American Roentgen Ray Society Images of Mucinous cystadenocarcinoma natural history |
|
Directions to Hospitals Treating Mucinous cystadenocarcinoma |
|
Risk calculators and risk factors for Mucinous cystadenocarcinoma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Ammu Susheela, M.D. [3]
Overview
If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself. Common complications of mucinous cystadenocarcinoma include metastasis and inguinal hernia. The presence of metastasis is associated with a particularly poor prognosis among patients with mucinous cystadenocarcinoma.
Natural History
- If left untreated, most of the patients with mucinous cystadenocarcinoma may be confined to the organ itself. Some of them may develop metastasis to the gastrointestinal tract.[1]
Complications
- Common complications are:
Prognosis
- Advanced stages of mucinous cystadenocarcinoma have an inferior prognosis.
- Mucinous cystadenocarcinoma has a much more favorable prognosis than most other forms of adenocarcinoma. Cases have been documented of continued growth of these lesions over a period of 10 years without symptoms or metastasis. The overall mortality rate appears to be somewhere in the vicinity of 18% to 27%, depending on the criteria that are used to define this entity.
- 5-year survival has been stated to be approximately 50% when treated with cytoreduction (debulking) surgery to remove all of the tumors in the abdomen which is combined with hyperthermic intraoperative peritoneal chemotherapy (HIPEC).
References
- ↑ Guruprasad, Bhat (2012). "Mucinous cystadenocarcinoma of ovary: Changing treatment paradigms". World Journal of Obstetrics and Gynecology. 1 (4): 42. doi:10.5317/wjog.v1.i4.42. ISSN 2218-6220.